09/14(2016 10:25:44 AM FROM:LABCORPLCLSFO TO: LABCORP

09/14(2016 10:25:44 AM FROM:LABCORPLCLSFO TO: LABCORP TO: LISA P Woodson Merre Page 1 of 9 r L ?Agin,Specamm Numb., 252-436-4247-0 Put klotIO Control Mamba 10416404914 Atoms Number 31143092 Account R Number Rowe I 68 Nbmc Um Nnw Epstein Anon Address Woodson Merrell 44 E 67th St New York NY 10065 PaimaimNme Jeffrey PuMwMADeNmx PadeaSP PricaMmac 212-750-9895 TwalVokame ar(Ymm) 63/07/19 Dared Binh 01/20/53 Sex M Fladas Yes Patna Address 9 E 71ST ST NEW YORK NY 10021 Adair/boil lobnintioo UPIN: A62553 nmeusinreColkaed 09/08/16 08:23 DneEmmed 09/08/16 DmearAlimeRepited 09/13/16 15:06ET ProichaName MERRELL , W NIM I Physician ID LabCorp Raritan 69 First Avenue Raritan. NJ 08869-1800 • - - Tout Ordeal NKR LipoProfile; Heavy Metals Profile II, Blood; CBC With Differential/Platelet; Comp. Metabolic Panel (14); IFE and PE, Serum; Urinalysis, Routine; Lipid Panel; Iron and TIBC; Testosterone,Free+Weakly Bound; Ca+PTH Intact; Vitamin B12 and Folate; Lyme Ab/Western Blot Reflex; Hemoglobin Alc; Thyroxine (T4) Free, Direct, S; DHEA-Sulfate; Cortisol; TSH; Rheumatoid Arthritis Factor; Prostate -Specific Ag, Serum; IGF-1; Vitamin D, 25-Hydroxy; Panel 083935; C-Reactive Protein, Cardiac; HCV Ab w/Rflx to Verification; ANA w/Reflex; Homocyst(e)ine, Plasma; Uric Acid, Serum; LDH; GGT; Magnesium, Serum; Zinc, Plasma or serum; Insulin; Ferritin, Serum; Test Code Change; Venipuncture TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAS tiHR LipoProfile LDL Particle Number LDL-P 1562 High nmol/L Low Moderate Borderline -High High Very High Lipids LDL-C Triglyceride result indicated is cholesterol estimation. comment: LDL-C is inaccurate HDL-C Triglycerides Cholesterol, Total LDL and HDL Particles HDL-P (Total) Small LDL-P LDL Size <1000 < 1000 1000 - 1299 1300 - 1599 1600 - 2000 > 2000 mg/dL 0 too high for an accurate LDL Optimal Above optimal Borderline High Very high if patient is non-fasting. 27 Low mg/d1, 476 High 214 High mg/dL 22.5 Low 1243 High 19.7 umol/L nmol/L nm - 99 100 - 130 - 160 - 100 129 159 189 189 >39 0 - 149 100 - 199 >=30.5 <=527 >20.5 01 01 01 01 01 01 01 01 01 01 01 Epstein, Jeffrey 09/14/16 10:25 ET DUPLICATE FINAL REPORT This dcaunent contains private and confidential health information protected by slat and federal law. If you have received this document in era please call 800-631-S2SO 252-436-4247-0 Scg N 8516 Page 1 of 8 020C4-16iabcratay Corpontioo of America e Holdings All Rights Relined DOCI Vet: 1.49 EFTA00287152 09/1412016 10:25:44 AM FROM: LABCORP LCLS Fe TO: LAsconi, TO: LISA P Woodson Merreill Page 2 of 9 r LabCorp Raritan 69 First Avenue Raritan, N1 0886 1800 : - Pagan Nam Epstein, Jeffrey Specimmigumber 252-436-4247-0 Ammar Number 31143092 Peeled ID Control Number 10416404914 Date and Thee Collected 09/08/16 08:23 D tieRepotted 09/13/16 Sa M Age(NANIM 63/07/19 I/Annie& 01/20/53 TESTS RESULT ELAG UNITS REITOUNICE INTERVAL LAB ** INTERPRETATIVE INFORMATION** PARTICLE CONCENTRATION AND SIZE <--Lower CVD Risk Higher CVD Risk--> LDL AND HDL PARTICLES Percentile in Reference Population HDL-P (total) High 75th 50th 25th Low >34.9 34.9 30.5 26.7 <26.7 Small LDL-P Low 25th 50th 75th High <117 117 527 839 >839 LDL Size <-Large (Pattern A)-> <-Small (Pattern B)-> 23.0 20.6 20.5 19.0 Comment: Small LDL-P and LDL Size are associated with CVD risk, but not after LDL-P is taken into account. These assays were developed and their performance characteristics determined by LipoScience. These assays have not been cleared by the US Food and Drug Administration. The clinical utility of these laboratory values have not been fully established. Insulin Resistance Score LP-IR Score 91 High <=45 INSULIN RESISTANCE MARKER <--Insulin Sensitive Insulin Resistant--> Percentile in Reference Population insulin Resistance Score LP-IR Score Low 25th 50th 75th High <27 27 45 63 >63 Comment: LP-IR Score is inaccurate if patient is non-fasting. The LP-IR score is a laboratory developed index that has been associated with insulin resistance and diabetes risk and should be used as one component of a physician's clinical assessment. The LP-IR score listed above has not been cleared by the US Food and Drug Administration. 01 01 01 01 Heavy Metals Profile II, Blood Lead, Blood None Detected ug/dL 0 - 19 01 Environmental Exposure: WHO Recommendation <20 Occupational Exposure: OSHA Lead Std 40 BEI 30 Detection Limit = 1 Epstein, Jeffrey 09/14/16 10:25 ET DUPLICATE FINAL REPORT This document contains private and ccalidential health Information protected by In and federal law. If you have received ibis document in arar. please call 800-631-5250 252-436-4247-0 SegOSM6 Page 2 of 8 02024- I 6 Labceatory Corporation of America m Holdings All Rights Reserved DOCI Va: 149 EFTA00287153 09/14/2018 10:25:44 AM FROM:LABCORPLCUSF0 TO: LABCORP TO: LISA P Woodson Merrell Page 3 of 9 r L.A.Csarp Patios Nave Epstein, Jeffrey Spodmen Number 252-436-4247-0 Amami Number 31143092 PMea ID Coal Number 10416909919 Dale ad Time Colluded 09/08/16 08:23 Dam Repotted 09/13/16 Sec M Age(YIM/D) 63/07/19 Date of Beth 01/20/53 TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAS Arsenic, Blood 4 ug/L 2 - 23 01 Detection Limit = 1 Mercury, Blood 2.2 ug/L 0.0 - 14.9 01 Environmental Exposure: <15.0 Occupational Exposure: BEI - Inorganic Mercury: 15.0 Detection Limit = 1.0 Cadmium, Blood None Detected ug/L 0.0 - 1.2 01 Environmental Exposure: Nonsmokers 0.3 - 1.2 Smokers 0.6 - 3.9 Occupational Exposure: OSHA Cadmium Std 5.0 BEI 5.0 Detection Limit = 0.5 CBC With Differential/Platelet WBC 5.8 x10E3/uL 3.4 10.8 02 RBC 4.95 x10E6/uL 4.14 5.80 02 Hemoglobin 14.1 g/dL 12.6 17.7 02 Hematocrit 41.9 8 37.5 51.0 02 MCV 85 fL 79 97 02 MCH 28.5 pg 26.6 33.0 02 MCHC 33.7 31.5 35.7 02 ROW 14.4 12.3 15.4 02 Platelets 232 xl0E3/uL 150 379 02 Neutrophils 51 8 02 Lymphs 32 8 02 Monocytes 9 8 02 Hos 7 8 02 Basos 1 8 02 Neutrophils (Absolute) 3.0 x10E3/uL 1.4 7.0 02 Lymphs (Absolute) 1.8 x10E3/uL 0.7 3.1 02 Monocytes(Absolute) 0.5 x10E3/uL 0.1 0.9 02 Eos (Absolute) 0.4 x10E3/uL 0.0 0.4 02 Baso (Absolute) 0.0 xl0E3/uL 0.0 0.2 02 Immature Granulocytes 0 8 02 Immature Grans (Abs) 0.0 x10E3/UL 0.0 - 0.1 02 Comp. Metabolic Panel (14) Glucose, Serum 96 mg/dL 65 - 99 02 BUN 16 mg/c1L 8 - 27 02 Creatinine, Serum 0.94 mg/dL 0.76 - 1.27 02 eGFR If NonAfricn Am 86 mL/min/1.73 >59 eGFR If Africn Am 99 mL/min/1.73 >59 LabCorp Raritan 69 First Avenue Raritan. NJ 08869-1800 Phone: 800-631-5250 Epstein, Jeffrey 252-436-4247-0 SIN 48516 09/14/16 10:25 ET DUPLICATE FINAL REPORT This dccwnent contains titivate and confidential health information protected by state and federal If you have received this domurient in error, please call 200-631-5230 Page 3 of 8 C2004-16 Laboratory Comondon of America m Holdings All Rights Reserved DOCI Ver 1.49 EFTA00287154 09/141201610:25:444AM FROM:LABCORPLCLSFs TO: LABCORP TO: LISA P Woodson Merrell Page 4 of 9 r Lalaggrap pastoral= Epstein, Jeffrey 4ralatomiabo 252-436-4247-0 Accoaot Number 31143092 Nom ID Coon) Number 10416404914 Date awl Time Collected 09/08/16 08:23 Doe Repotted 09/13/16 Sex M Ase(YrtND) 63/07/19 Due of Bid, 01/20/53 TESTS RESULT FLAG BUN/Creatinine Ratio Sodium, Serum Potassium, Serum Chloride, Serum Carbon Dioxide, Total Calcium, Serum Protein, Total, Serum Albumin, Serum Globulin, Total A/G Ratio Bilirubin, Total 17 139 4.4 99 22 9.5 6.7 4.3 2.4 1.8 0.8 Alkaline Phosphatase, S 63 AST (SGOT) 30 ALT (SGPT) 42 IFE and PE, Serum Immunoglobulin G, Qn, Serum 1056 Immunoglobulin A, Qn, Serum 224 Immunoglobulin M, Qn, Serum 42 Albumin 3.6 Alpha -I-Globulin 0.2 Alpha -2-Globulin 0.8 Beta Globulin 1.0 Gamma Globulin 1.0 M-Spike Not Observed Globulin, Total 3.1 A/G Ratio 1.2 LibCorp Raritan 69 First Avenue Raritan. NJ 08869-1800 Phone: 800-631-5250 UNITS strounics INTERVAL mmol/L mmol/L mmol/L mmol/L mg/dL g/dL g/dL g/dL mg/dL IU/L IU/L IU/L mg/dL mg/dL mg/dL g/dL g/dL g/dL g/dL g/dL g/dL g/dL Immunofixation Result, Serum An apparent normal immunofixation pattern. Please note: Protein electrophoresis scan will follow via computer, courier delivery. Urinalysis, Routine Urinalysis Gross Exam specific Gravity PH Urine -Color Appearance WBC Esterase Protein Glucose Ketones Occult Blood Bilirubin Urobilinogen,Semi-Qn Nitrite, Urine 1.028 5.5 Yellow Clear Negative Negative Negative Negative Trace Negative 0.2 Negative Abnormal EU/dL 10 22 134 144 02 3.5 5.2 02 97 108 02 18 29 02 8.6 10.2 02 6.0 8.5 02 3.6 4.8 02 1.5 4.5 1.1 2.5 0.0 1.2 02 39 117 02 0 40 02 0 44 02 700 1600 02 61 437 02 20 172 02 2.9 4.4 02 0.0 0.4 02 0.4 1.0 02 0.7 1.3 02 0.4 1.8 02 Not Observed 02 2.2 - 3.9 0.7 - 1.7 02 mail, or 02 02 1.005 - 1.030 02 5.0 - 7.5 02 Yellow 02 Clear 02 Negative 02 Negative/Trace 02 Negative 02 Negative 02 Negative 02 Negative 02 0.2 - 1.0 02 Negative 02 Epstein, Jeffrey 09/14/16 10:25 ET DUPLICATE FINAL REPORT This document contains private and confidential health information ',mind by stale and federal law. If you have received this document in woe. please call 800-631-5250 252-436-4247-0 Seq/18M6 Page 4 of 8 02004-14GbaatayCorpomficmaAmmica011oldings AUFtightsResaved DOC1VerAA9 EFTA00287155 09/14/2016 10:25:44 AM FROM:LABCORPLCLSF8 LABCORP TO: LISA P Woodson Merre Page 5 of 9 r LAkCosarP ItadomName Epstein, Jeffrey SeecitheaNtotther 252-436-4247-0 Accaux ?Iamb« 31143092 Pas ID Cocoa Nuatee 10416404914 Due end Thee Coleus 09/08/16 08:23 Due Reported 09/13/16 Sec M Age(WAVD) 63/07/19 Due of Bid. 01/20/53 LabCorp Raritan 69 First Avenue Raritan, NJ 08869-1800 Phone: 800- - TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAS Microscopic Examination WBC BBC Epithelial Cells (non renal) Mucus Threads Bacteria Lipid Panel Cholesterol, Total Triglycerides HDL Cholesterol Comment See below: 0-5 0-2 /hpf /hpf 0 - 5 0 - 2 None seen /hpf 0 - 10 Present Not Estab. None seen None seen/Few 214 High mg/dL 100 - 199 470 High mg/dL 0 - 149 27 Low mg/dL >39 According to ATP-III Guidelines, HDL-C >59 mg/dL negative risk factor for CHD. VLDL Cholesterol Cal The calculation for the VLDL cholesterol triglyceride level is >400 mg/dL. LDL Cholesterol Calc Triglyceride result indicated is too high for cholesterol estimation. Iron and TIBC Iron Bind.Cap.(TIBC) UIBC Iron, Serum Iron Saturation 302 219 83 27 Testosterone, Free+Weakly Bound Testosterone, Serum 153 Low Comment: Adult male reference interval is based on a population up to 40 years old. Testost., 9 Free+Weakly Bound Testost., F+W Bound Ca+PTH Intact PTH, Intact Intact PTH 31.6 48.3 ng/dL 40.0 - 250.0 is considered a mg/dL is not valid when 5 - 40 mg/dL 0 - 99 an accurate LDL ug/dL ug/dL ug/dL 250 - 450 111 - 343 38 - 169 15 - 55 02 02 02 02 02 02 02 02 02 02 02 02 ng/dL 348 - 1197 02 of lean males 9.0 - 46.0 01 65 Interpretation Normal Primary Hyperparathyroidism Secondary Hyperparathyroidism Non-Parathyroid Hypercalcemia Hypoparathyroidism pg/mL Intact PTH (pg/mL) 15 - 65 >65 >65 <65 <15 15 - 65 02 02 Calcium (mg/dL) 8.6 - 10.2 >10.2 <10.2 >10.2 < 8.6 Epstein, Jeffrey 252-436-4247-0 Seq08516 09/14/16 10325 ET DUPLICATE FINAL REPORT This dectunentcontalns print and confidential health infonnadon protected by state and federal law. If you have received this doctunent in MCC please call 800 -631-5250 Page 5 of 8 O2004-16 Labontay Corporation &America S Holdings All Rights Reserved DOC1 Va: 1.49 EFTA00287156 09114/201610:25:44AM FROM:LABCORPLCISF6 TO: LABCORP TO: LISA P Woodson Merrell Page 6 of 9 r Labgrap ibthaNum Epstein, Jeffrey SpecharmNurber 252-436-4247-0 Ana Sao 31143092 Nem M Comet Nat 10416404914 Dee aornme Conected 09/08/16 08:23 Date Mowed 09/13/16 Sc M Age(Y/M0) 63/07/19 Date of Birth 01/20/53 TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Non-Parathyroid Hypocalcemia Vitamin B12 and Folate 15 - 65 < 8.6 Vitamin 812 945 pg/mL 211 - 946 02 Folate (Folic Acid), Serum 9.9 ng/m1, >3.0 02 Note: 02 A serum folate concentration of less than 3. considered to represent clinical deficiency. 1 ng/mL is Lyme Ab/Western Blot Reflex Lyme IgG/IgM Ab <0.91 ISR 0.00 - 0.90 02 Negative <0.91 Equivocal 0.91 - 1.09 Positive >1.09 Lyme Disease Ab, Quant, IgM <0.80 index 0.00 - 0.79 02 Negative <0.80 Equivocal 0.80 - 1.19 Positive >1.19 IgM levels may peak at 3-6 weeks post infection, then gradually decline. Hemoglobin Aic Hemoglobin Aic 5.8 High 4.8 - 5.6 Please Note: 02 02 Pre-diabetes: 5.7 - 6.4 Diabetes: >6.4 Glycemic control for adults with diabetes: <7.0 Thyroxine (T4) Free, Direct, S T4,Pree(Direct) 1.13 ng/dL 0.82 - 1.77 02 DBEA-Sulfate 155.3 ug/dL 48.9 - 344.2 02 cortisol 14.1 ug/dL 02 Cortisol AM 6.2 - 19.4 Cortisol PH 2.3 - 11.9 TSB 1.800 uIU/mL 0.450 - 4.500 02 Rheumatoid Arthritis rector RA Latex Turbid. 5.8 IUML 0.0 - 13.9 02 LabCorp Raritan 69 First Avenue Raritan NJ 08869-1800 Phone: 800-631-5250 Epstein, Jeffrey 09/14/16 10:25 ET DUPLICATE FINAL REPORT This document cornaim private and confidential health information protected by slate and federal law. If you have received this document m error, please call 800-631-5250 252-436-4247-0 Seq I 8516 Page 6 of 8 02001-16 Laboratory Corporation d America m Holdings AU Rights Reserved DOC I Ver: 149 EFTA00287157 09114/201610:25:44AM FROM:LABCORPLCUSFe LABCORP TO: LISA P Woodson Me Page 7 of 9 r LQ,bQcarwp Patient Name Epstein, Jeffrey Spedmeo Number 252-436-4247-0 Account Number 31143092 Norm ID Coaxed Number 10416404914 Dam sod Time Collected 09/08/16 08:23 Dae Rmoned 09/13/16 St= M Area/WD) 63/07/19 Date of Bit) 01/20/53 LabCorp Raritan 69 First Avenue Raritan NJ 08869-1800 Phone: 800-631-5250 TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Prostate -Specific Ag, Serum Prostate Specific Ag, Serum Roche ECLIA methodology. 0.6 ng/mL 0.0 - 4.0 According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory PSA value 0.2 ng/mL or greater. Values obtained with different assay methods or kits cannot be used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. IGF-1 Insulin -Like Growth Factor I 151 ng/ra. 02 49 - 188 01 Vitamin D, 25-Hydroxy 34.0 ng/mL 30.0 - 100.0 02 Vitamin D deficiency has been defined by the Institute of Medicine and an Endocrine Society practice guideline as a level of serum 25-OH vitamin D less than 20 ng/mL (1,2). The Endocrine Society went on to further define vitamin D insufficiency as a level between 21 and 29 ng/mL (2). 1. IOM (Institute of Medicine). 2010. Dietary reference intakes for calcium and D. Washington DC: The National Academies Press. 2. Holick MF, Hinkley NC, Bischoff -Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine society clinical practice guideline. JCEM. 2011 Jul; 96(7):1911-30. Panel 083935 HIV Screen 4th Generation wRfx Non Reactive Non Reactive 02 C-Reactive Protein, Cardiac HCV Ab w/Rflx to Verification HCV Ab Comment: Non reactive HCV antibody screen is consistent with no unless recent infection is suspected or other evidence indicate HCV infection. 3.39 High mg/L 0.00 - 3.00 Relative Risk for Future Cardiovascular Event LOW <1.00 Average 1.00 - 3.00 High >3.00 <0.1 s/co ratio 02 0.0 - 0.9 02 02 HCV infection, exists to Epstein, Jeffrey 252-436-4247-0 Seq #8516 09/14/16 10:25 ET DUPLICATE FINAL REPORT This document contains private and confidential health information protected by state and federal law. lf you have received this document in error, please call 800-631-5250 Page 7 of 8 02004-16 Laboratory Corporation of America 0 Holdings All Rights Reserved DOCI Vet 1.49 EFTA00287158 09/14/2016 10:25:44 AM FROM: LABCORP LCLS F6 T LABCORP TO: LISA P Woodson M Pegs 8 of 9 r L&Qcsp DeiccoName Epstein, Jeffrey Specimen Hunter 252-436-4247-0 Mooing Hinter 31143092 Poirot M Oman) Nuts 10416404914 Dow and Thus °Awed 09/08/16 08:23 Das Reporeed 09/13/16 Sot M Ase0(440 63/07/19 Date of Birds 01/20/53 LabCorp Raritan 69 First Avenue Raritan NJ 08869-1800 Phes6:800 -631 -5250 TESTS ANA w/Reflex ANA Direct Romocyst(e)ine, Plasma Uric Acid, Serum Uric Acid, Serum Please Note: LDH GGT Magnesium, Serum Zinc, Plasma or Serum Insulin Ferritin, Serum Test Code Change RESULT FLAG UNITS REFERENCE INTERVAL LAB Negative Negative 02 16.0 High umol/L 0.0 - 15.0 02 7.1 mg/dL 3.7 - 8.6 02 02 Therapeutic target for gout patients: <6.0 171 IU/L 121 - 224 02 24 IU/L 0 65 02 2.0 mg/dL 1.6 - 2.3 02 89 ug/dL 56 - 134 01 Detection Limit = 5 11.1 uIU/mL 2.6 - 24.9 02 98 ng/mL 30 - 400 02 02 **Effective May 8, 2016, HIV-1/0/2 Antibodies, Preliminary Test with** Confirmation (Third Generation) has been discontinued. Please note the HIV-1/0/2 Antibodies, Preliminary Test with Confirmation was updated to HIV-1/0/2 Antigen/Antibody (Fourth Generation) Preliminary Test with cascade reflex to Supplementary Testing by LabCorp. For future orders, please use the HIV-1/O/2 Antigen/Antibody test number 083935. Contact your LabCorp Key Account Executive to request new custom profile(s) containing 083935. 01 BN LabCorp Burlington 1447 York Court, Burlington, 02 RN LabCorp Raritan 69 First Avenue, Raritan, NJ For inquiries, the physician nay contact Dir: William F Hancock, ND NC 27215-3361 Dir: Araceli B Reyes, ND 08869 -1800 Branch: 800-631-5250 Lab: 800-631-5250 Epstein, Jeffrey 09/14/16 10:25 ET DUPLICATE FINAL REPORT This document canal= pint and confldentid health infonnatioo protected by state and federal law. if you have received this document in trite. please call 800-631-5250 252-436-4247-0 Sag # 8516 Page 8 of B 02004-16 Laboratory Corporation of America S Holdings All Rights Reserved DOCI Vez: 149 EFTA00287159 Lata Militia ST Woodson Merre Special Chemistry Department Raritan New Jersey Serum Immunofixation and Electrophoresis raga 9 or Serum Proteins IFE Gel T44385 Sample 45 09/09/2016 13:51:29:44 252436424709 Accession Number 252436424709 Physician ID MERRELL W Patient Name Epstein, Jeffrey Account Address 1 Total Protein 6.7 Account Address 2 44 E 67th St Patient ID Account Address 3 New York, NY 10065 Birthdate 1/20/1953 Account No./Name 31143092 -Woodson Merrell Fraction % g/dl g/dl Range Albumin 53.9 3.6 3.2 to 5.6 Alpha-1 3.0 0.2 0.1 to 0.4 Alpha-2 12.6 0.8 0.4 to 1.2 Beta 15.4 1.0 0.6 to 1.3 Gamma 15.0 1.0 0.5 to 1.6 Total 6.7 6.0 to 8.5 Comments An apparent normal immundIxatIon pattern. EFTA00287160